Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Novartis AG (NVS)

93.31   -0.11 (-0.12%) 03-25 16:02
Open: 93.57 Pre. Close: 93.42
High: 93.66 Low: 92.9
Volume: 1,363,662 Market Cap: 216293M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 93.7 - 94.33 94.33 - 94.852
Low: 91.674 - 92.297 92.297 - 92.814
Close: 92.398 - 93.409 93.409 - 94.246

Technical analysis

as of: 2019-03-25 4:30:47 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 109.66     One year: 128.09
Support: Support1: 90.71    Support2: 88.75
Resistance: Resistance1: 93.89    Resistance2: 109.66
Pivot: 91.72
Moving Average: MA(5): 93.37     MA(20): 91.53
MA(100): 88.47     MA(250): 83.70
MACD: MACD(12,26): 1.14     Signal(9): 0.97
Stochastic oscillator: %K(14,3): 91.68     %D(3): 91.85
RSI: RSI(14): 67.23
52-week: High: 93.89  Low: 72.30  Change(%): 17.1
Average Vol(K): 3-Month: 198418  10-Days: 227136

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NVS has closed below upper band by 25.9%. Bollinger Bands are 25.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 23 Mar 2019 00:11:37 Z
Conatus (CNAT) Declines on Failure of NASH Fibrosis Study

Fri, 22 Mar 2019 17:11:56 Z
Biogen Stock Crashes on Termination of Alzheimer's Studies

Thu, 21 Mar 2019 16:15:28 Z
Cooper Companies' (COO) CooperVision Gains Momentum Globally

Wed, 20 Mar 2019 17:09:39 Z
Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan

Wed, 20 Mar 2019 17:09:24 Z
Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2311.17
Shares Float (M) 2311.17
% Held by Insiders
% Held by Institutions 15.20
Shares Short (K) 2118
Shares Short P. Month (K)

Stock Financials

EPS 5.090
EPS Est. Current Year 4.750
EPS Est. Next Year 5.250
EPS Est. Next Quarter 1.280
Forward EPS 5.631
Book Value (p.s.) 2.730
PEG Ratio 2.47
Profit Margin 24.38
Operating Margin 19.36
Return on Assets (ttm) 9.1
Return on Equity (ttm) 16.6
Qtrly Rev. Growth 3.8
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth -39.50
Operating Cash Flow (M) 14270.00
Levered Free Cash Flow (M) 10470.00

Stock Valuations

P/E 18.33
P/E Growth Ratio
P/BV 34.18
P/S 9404280832.00
P/CF 15.11

Dividends & Splits

Dividend 3.034
Dividend Yield 0.03
Dividend Pay Date 2019-03-13
Ex-Dividend Date 2019-03-04
Forward Dividend 2.830
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.